

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 6.94651888 |
| 2 | cellular response to exogenous dsRNA (GO:0071360) | 6.59728606 |
| 3 | hydrogen peroxide biosynthetic process (GO:0050665) | 6.06150707 |
| 4 | neutrophil activation involved in immune response (GO:0002283) | 6.01214180 |
| 5 | natural killer cell mediated cytotoxicity (GO:0042267) | 5.75210929 |
| 6 | natural killer cell mediated immunity (GO:0002228) | 5.75210929 |
| 7 | respiratory burst (GO:0045730) | 5.70407379 |
| 8 | regulation of helicase activity (GO:0051095) | 5.47764530 |
| 9 | cellular response to interferon-beta (GO:0035458) | 5.43418575 |
| 10 | reactive oxygen species biosynthetic process (GO:1903409) | 5.35844720 |
| 11 | regulation of RIG-I signaling pathway (GO:0039535) | 5.23276184 |
| 12 | intracellular pH reduction (GO:0051452) | 5.18560324 |
| 13 | phagocytosis, recognition (GO:0006910) | 5.16171271 |
| 14 | positive regulation of monocyte chemotaxis (GO:0090026) | 4.99014352 |
| 15 | eosinophil chemotaxis (GO:0048245) | 4.93131661 |
| 16 | cellular response to type I interferon (GO:0071357) | 4.77020637 |
| 17 | type I interferon signaling pathway (GO:0060337) | 4.77020637 |
| 18 | superoxide anion generation (GO:0042554) | 4.71983479 |
| 19 | protein carboxylation (GO:0018214) | 4.68076847 |
| 20 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.68076847 |
| 21 | pH reduction (GO:0045851) | 4.65755704 |
| 22 | response to type I interferon (GO:0034340) | 4.64959954 |
| 23 | cellular response to interferon-alpha (GO:0035457) | 4.58613709 |
| 24 | negative regulation of viral genome replication (GO:0045071) | 4.47082168 |
| 25 | cellular response to zinc ion (GO:0071294) | 4.42706832 |
| 26 | regulation of meiosis I (GO:0060631) | 4.40026259 |
| 27 | positive regulation of vesicle fusion (GO:0031340) | 4.37908497 |
| 28 | defense response to protozoan (GO:0042832) | 4.34197159 |
| 29 | eosinophil migration (GO:0072677) | 4.32211694 |
| 30 | response to interferon-beta (GO:0035456) | 4.25132602 |
| 31 | regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039531) | 4.24457541 |
| 32 | barbed-end actin filament capping (GO:0051016) | 4.17474228 |
| 33 | production of molecular mediator involved in inflammatory response (GO:0002532) | 4.12434674 |
| 34 | positive regulation of endothelial cell apoptotic process (GO:2000353) | 4.11829584 |
| 35 | serine family amino acid catabolic process (GO:0009071) | 4.11536596 |
| 36 | regulation of mononuclear cell migration (GO:0071675) | 4.04462216 |
| 37 | positive regulation of interferon-alpha production (GO:0032727) | 4.02741493 |
| 38 | immunoglobulin mediated immune response (GO:0016064) | 3.89486365 |
| 39 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 3.86798118 |
| 40 | positive regulation of DNA recombination (GO:0045911) | 3.82606708 |
| 41 | regulation of interferon-alpha production (GO:0032647) | 3.75415719 |
| 42 | sequestering of actin monomers (GO:0042989) | 3.70949747 |
| 43 | regulation of monocyte chemotaxis (GO:0090025) | 3.66517262 |
| 44 | response to protozoan (GO:0001562) | 3.63795612 |
| 45 | neutrophil activation (GO:0042119) | 3.62300528 |
| 46 | regulation of glutamate secretion (GO:0014048) | 3.58214978 |
| 47 | regulation of defense response to virus by host (GO:0050691) | 3.54709401 |
| 48 | positive regulation of interferon-beta production (GO:0032728) | 3.52863713 |
| 49 | regulation of hypersensitivity (GO:0002883) | 3.47802386 |
| 50 | granulocyte activation (GO:0036230) | 3.43300653 |
| 51 | myeloid cell homeostasis (GO:0002262) | 3.39945375 |
| 52 | positive regulation of natural killer cell differentiation (GO:0032825) | 3.36042401 |
| 53 | negative regulation of interleukin-8 production (GO:0032717) | 3.27513684 |
| 54 | hydrogen peroxide metabolic process (GO:0042743) | 3.24669727 |
| 55 | regulation of cholesterol storage (GO:0010885) | 3.19793037 |
| 56 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 3.18139348 |
| 57 | G-protein coupled purinergic receptor signaling pathway (GO:0035588) | 3.17517544 |
| 58 | regulation of chemokine-mediated signaling pathway (GO:0070099) | 3.13518187 |
| 59 | positive regulation of protein kinase C signaling (GO:0090037) | 3.11612756 |
| 60 | superoxide metabolic process (GO:0006801) | 3.11534361 |
| 61 | positive regulation of antigen processing and presentation (GO:0002579) | 3.09151688 |
| 62 | adenosine receptor signaling pathway (GO:0001973) | 3.08119929 |
| 63 | response to interferon-alpha (GO:0035455) | 3.07566225 |
| 64 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.04855407 |
| 65 | leukocyte mediated cytotoxicity (GO:0001909) | 3.03081709 |
| 66 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.00786142 |
| 67 | cellular response to oxygen radical (GO:0071450) | 2.96239756 |
| 68 | removal of superoxide radicals (GO:0019430) | 2.96239756 |
| 69 | cellular response to superoxide (GO:0071451) | 2.96239756 |
| 70 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.95178334 |
| 71 | positive regulation of response to biotic stimulus (GO:0002833) | 2.94971802 |
| 72 | aldehyde catabolic process (GO:0046185) | 2.93694603 |
| 73 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 2.93206803 |
| 74 | positive regulation of calcium ion import (GO:0090280) | 2.91652259 |
| 75 | phagosome maturation (GO:0090382) | 2.88433727 |
| 76 | negative regulation of viral process (GO:0048525) | 2.87367991 |
| 77 | regulation of intracellular pH (GO:0051453) | 2.86935579 |
| 78 | heme metabolic process (GO:0042168) | 2.86853586 |
| 79 | positive regulation of inflammatory response to antigenic stimulus (GO:0002863) | 2.83466844 |
| 80 | macrophage chemotaxis (GO:0048246) | 2.82794746 |
| 81 | monocyte chemotaxis (GO:0002548) | 2.82409633 |
| 82 | hydrogen peroxide catabolic process (GO:0042744) | 2.81488737 |
| 83 | glycosphingolipid catabolic process (GO:0046479) | 2.80532840 |
| 84 | regulation of interleukin-8 secretion (GO:2000482) | 2.80122598 |
| 85 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 2.79307615 |
| 86 | negative regulation of B cell proliferation (GO:0030889) | 2.78422839 |
| 87 | glycine metabolic process (GO:0006544) | 2.78106081 |
| 88 | heme biosynthetic process (GO:0006783) | 2.72870525 |
| 89 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.72234678 |
| 90 | negative regulation of cell killing (GO:0031342) | 2.72234678 |
| 91 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.70958002 |
| 92 | negative regulation of T cell receptor signaling pathway (GO:0050860) | 2.67772570 |
| 93 | positive regulation of tyrosine phosphorylation of Stat1 protein (GO:0042511) | 2.67735880 |
| 94 | cytokine secretion (GO:0050663) | 2.67690104 |
| 95 | low-density lipoprotein particle clearance (GO:0034383) | 2.66672059 |
| 96 | membrane raft organization (GO:0031579) | 2.66156480 |
| 97 | regulation of cellular pH (GO:0030641) | 2.65101942 |
| 98 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.63710162 |
| 99 | negative regulation of protein localization to cell surface (GO:2000009) | 2.59641855 |
| 100 | regulation of isotype switching to IgG isotypes (GO:0048302) | 2.57375543 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 9.14490899 |
| 2 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 7.17202665 |
| 3 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 7.03995401 |
| 4 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 4.62965363 |
| 5 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 4.61537719 |
| 6 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.57892205 |
| 7 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 3.35781091 |
| 8 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.23275194 |
| 9 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.93431802 |
| 10 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.88380445 |
| 11 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.78233264 |
| 12 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.54254900 |
| 13 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.37531119 |
| 14 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.96739788 |
| 15 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.95823565 |
| 16 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.92754536 |
| 17 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.83269127 |
| 18 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.72175455 |
| 19 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.66033508 |
| 20 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.62057631 |
| 21 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.59149119 |
| 22 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.55388203 |
| 23 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.55388203 |
| 24 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.54006766 |
| 25 | CJUN_26792858_Chip-Seq_BT549_Human | 1.51849731 |
| 26 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.45072879 |
| 27 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.40718064 |
| 28 | VDR_22108803_ChIP-Seq_LS180_Human | 1.40171165 |
| 29 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.38283972 |
| 30 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.35403753 |
| 31 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.35142101 |
| 32 | MYB_26560356_Chip-Seq_TH2_Human | 1.34594791 |
| 33 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.33166545 |
| 34 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.32891105 |
| 35 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.31540698 |
| 36 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.30576986 |
| 37 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.27388857 |
| 38 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.27080216 |
| 39 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.26602758 |
| 40 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.20956597 |
| 41 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.18912311 |
| 42 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.16303396 |
| 43 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.13573850 |
| 44 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.12200450 |
| 45 | GATA3_26560356_Chip-Seq_TH2_Human | 1.11828983 |
| 46 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.10313640 |
| 47 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.09762068 |
| 48 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.09446927 |
| 49 | MAF_26560356_Chip-Seq_TH1_Human | 1.05829349 |
| 50 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.04059725 |
| 51 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.03459201 |
| 52 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.01355805 |
| 53 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.00380251 |
| 54 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.00273436 |
| 55 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.00206875 |
| 56 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.98510821 |
| 57 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.98036446 |
| 58 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.94483539 |
| 59 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 0.94435408 |
| 60 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.94006865 |
| 61 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.92473246 |
| 62 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.91114008 |
| 63 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.90891917 |
| 64 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.90185341 |
| 65 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.88283109 |
| 66 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.87562920 |
| 67 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.87562920 |
| 68 | GATA3_27048872_Chip-Seq_THYMUS_Human | 0.87435477 |
| 69 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.85944144 |
| 70 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.85113714 |
| 71 | SPI1_23127762_ChIP-Seq_K562_Human | 0.85111831 |
| 72 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.81698438 |
| 73 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.80274980 |
| 74 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.74404455 |
| 75 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 0.74261245 |
| 76 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.72359168 |
| 77 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.72291561 |
| 78 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.70964011 |
| 79 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 0.70564274 |
| 80 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.69916376 |
| 81 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.69358077 |
| 82 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.69276235 |
| 83 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.68979016 |
| 84 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.68658260 |
| 85 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 0.67956839 |
| 86 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.65894816 |
| 87 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.64541811 |
| 88 | MYB_26560356_Chip-Seq_TH1_Human | 0.64046899 |
| 89 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.63678106 |
| 90 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.63605380 |
| 91 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 0.63094500 |
| 92 | VDR_21846776_ChIP-Seq_THP-1_Human | 0.62295753 |
| 93 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.61976767 |
| 94 | GATA1_19941826_ChIP-Seq_K562_Human | 0.61924249 |
| 95 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.61532557 |
| 96 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.60841653 |
| 97 | RXR_22108803_ChIP-Seq_LS180_Human | 0.60221216 |
| 98 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.60202807 |
| 99 | KLF5_25053715_ChIP-Seq_YYC3_Human | 0.59602046 |
| 100 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.58104046 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 4.35964241 |
| 2 | MP0002148_abnormal_hypersensitivity_rea | 3.89483966 |
| 3 | MP0009785_altered_susceptibility_to | 3.64499030 |
| 4 | MP0004510_myositis | 3.51257775 |
| 5 | MP0005671_abnormal_response_to | 3.43064068 |
| 6 | MP0003724_increased_susceptibility_to | 3.39470862 |
| 7 | MP0003436_decreased_susceptibility_to | 3.30811859 |
| 8 | MP0005025_abnormal_response_to | 3.10121272 |
| 9 | MP0003303_peritoneal_inflammation | 3.07560511 |
| 10 | MP0005000_abnormal_immune_tolerance | 3.01032336 |
| 11 | MP0002419_abnormal_innate_immunity | 2.76849000 |
| 12 | MP0003075_altered_response_to | 2.69692162 |
| 13 | MP0000685_abnormal_immune_system | 2.56632369 |
| 14 | MP0002877_abnormal_melanocyte_morpholog | 2.43404498 |
| 15 | MP0002090_abnormal_vision | 2.36465574 |
| 16 | MP0005387_immune_system_phenotype | 2.34273815 |
| 17 | MP0001790_abnormal_immune_system | 2.34273815 |
| 18 | MP0001853_heart_inflammation | 2.32927875 |
| 19 | MP0002138_abnormal_hepatobiliary_system | 2.25982743 |
| 20 | MP0002452_abnormal_antigen_presenting | 2.18646105 |
| 21 | MP0002723_abnormal_immune_serum | 2.17836566 |
| 22 | MP0006082_CNS_inflammation | 2.14999494 |
| 23 | MP0005248_abnormal_Harderian_gland | 2.07725222 |
| 24 | MP0005464_abnormal_platelet_physiology | 1.95543032 |
| 25 | MP0001819_abnormal_immune_cell | 1.94401475 |
| 26 | MP0001800_abnormal_humoral_immune | 1.91297507 |
| 27 | MP0003195_calcinosis | 1.89391917 |
| 28 | MP0004782_abnormal_surfactant_physiolog | 1.87987828 |
| 29 | MP0003448_altered_tumor_morphology | 1.86609394 |
| 30 | MP0002420_abnormal_adaptive_immunity | 1.84106804 |
| 31 | MP0003191_abnormal_cellular_cholesterol | 1.82037171 |
| 32 | MP0001845_abnormal_inflammatory_respons | 1.80943389 |
| 33 | MP0004947_skin_inflammation | 1.77275068 |
| 34 | MP0000604_amyloidosis | 1.75692453 |
| 35 | MP0005166_decreased_susceptibility_to | 1.69731377 |
| 36 | MP0001533_abnormal_skeleton_physiology | 1.68354659 |
| 37 | MP0005310_abnormal_salivary_gland | 1.57213301 |
| 38 | MP0002405_respiratory_system_inflammati | 1.55246698 |
| 39 | MP0005408_hypopigmentation | 1.50159652 |
| 40 | MP0003186_abnormal_redox_activity | 1.44100545 |
| 41 | MP0002332_abnormal_exercise_endurance | 1.37767069 |
| 42 | MP0001542_abnormal_bone_strength | 1.33364089 |
| 43 | MP0010155_abnormal_intestine_physiology | 1.30889735 |
| 44 | MP0008469_abnormal_protein_level | 1.26685742 |
| 45 | MP0000716_abnormal_immune_system | 1.24670497 |
| 46 | MP0005058_abnormal_lysosome_morphology | 1.22539791 |
| 47 | MP0010307_abnormal_tumor_latency | 1.22528689 |
| 48 | MP0002933_joint_inflammation | 1.21466239 |
| 49 | MP0001663_abnormal_digestive_system | 1.21133771 |
| 50 | MP0003705_abnormal_hypodermis_morpholog | 1.19382428 |
| 51 | MP0009840_abnormal_foam_cell | 1.18271448 |
| 52 | MP0005360_urolithiasis | 1.17930211 |
| 53 | MP0002398_abnormal_bone_marrow | 1.14456399 |
| 54 | MP0002166_altered_tumor_susceptibility | 1.10836854 |
| 55 | MP0003329_amyloid_beta_deposits | 1.07805891 |
| 56 | MP0002006_tumorigenesis | 1.06992444 |
| 57 | MP0005187_abnormal_penis_morphology | 1.05765805 |
| 58 | MP0000569_abnormal_digit_pigmentation | 1.05251479 |
| 59 | MP0003866_abnormal_defecation | 1.04966060 |
| 60 | MP0009764_decreased_sensitivity_to | 1.03880378 |
| 61 | MP0003690_abnormal_glial_cell | 1.02366660 |
| 62 | MP0004883_abnormal_blood_vessel | 1.01425363 |
| 63 | MP0010234_abnormal_vibrissa_follicle | 1.00872311 |
| 64 | MP0002136_abnormal_kidney_physiology | 1.00821579 |
| 65 | MP0005164_abnormal_response_to | 0.98517630 |
| 66 | MP0009763_increased_sensitivity_to | 0.97742241 |
| 67 | MP0005623_abnormal_meninges_morphology | 0.96512598 |
| 68 | MP0002429_abnormal_blood_cell | 0.95038208 |
| 69 | MP0005197_abnormal_uvea_morphology | 0.93790669 |
| 70 | MP0005167_abnormal_blood-brain_barrier | 0.93636646 |
| 71 | MP0000372_irregular_coat_pigmentation | 0.92393530 |
| 72 | MP0000343_altered_response_to | 0.92385757 |
| 73 | MP0001348_abnormal_lacrimal_gland | 0.90161137 |
| 74 | MP0003453_abnormal_keratinocyte_physiol | 0.90145182 |
| 75 | MP0003806_abnormal_nucleotide_metabolis | 0.89355788 |
| 76 | MP0001346_abnormal_lacrimal_gland | 0.88342229 |
| 77 | MP0000858_altered_metastatic_potential | 0.83364906 |
| 78 | MP0002998_abnormal_bone_remodeling | 0.82634513 |
| 79 | MP0005076_abnormal_cell_differentiation | 0.82294157 |
| 80 | MP0000371_diluted_coat_color | 0.81763632 |
| 81 | MP0002254_reproductive_system_inflammat | 0.81540027 |
| 82 | MP0009333_abnormal_splenocyte_physiolog | 0.80138970 |
| 83 | MP0005381_digestive/alimentary_phenotyp | 0.78982786 |
| 84 | MP0000689_abnormal_spleen_morphology | 0.77450658 |
| 85 | MP0005165_increased_susceptibility_to | 0.77051930 |
| 86 | MP0005023_abnormal_wound_healing | 0.76928631 |
| 87 | MP0002722_abnormal_immune_system | 0.76841409 |
| 88 | MP0003136_yellow_coat_color | 0.76453047 |
| 89 | MP0001915_intracranial_hemorrhage | 0.76264450 |
| 90 | MP0004130_abnormal_muscle_cell | 0.75383300 |
| 91 | MP0002139_abnormal_hepatobiliary_system | 0.75339700 |
| 92 | MP0006054_spinal_hemorrhage | 0.73416712 |
| 93 | MP0004858_abnormal_nervous_system | 0.72997905 |
| 94 | MP0001851_eye_inflammation | 0.71818153 |
| 95 | MP0005390_skeleton_phenotype | 0.68360111 |
| 96 | MP0008438_abnormal_cutaneous_collagen | 0.67601060 |
| 97 | MP0003656_abnormal_erythrocyte_physiolo | 0.67293857 |
| 98 | MP0004019_abnormal_vitamin_homeostasis | 0.64341184 |
| 99 | MP0003646_muscle_fatigue | 0.63868606 |
| 100 | MP0004272_abnormal_basement_membrane | 0.63724745 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Recurrent gram-negative bacterial infections (HP:0005420) | 7.02723369 |
| 2 | Eczematoid dermatitis (HP:0000976) | 6.78157600 |
| 3 | Recurrent abscess formation (HP:0002722) | 5.83017016 |
| 4 | Poor head control (HP:0002421) | 5.61895132 |
| 5 | Recurrent bacterial skin infections (HP:0005406) | 5.59908140 |
| 6 | Elevated erythrocyte sedimentation rate (HP:0003565) | 5.15918611 |
| 7 | Prolonged partial thromboplastin time (HP:0003645) | 4.88253007 |
| 8 | Basal ganglia calcification (HP:0002135) | 4.87295750 |
| 9 | Axonal loss (HP:0003447) | 4.81344081 |
| 10 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 4.80961687 |
| 11 | Systemic lupus erythematosus (HP:0002725) | 4.80609419 |
| 12 | Joint hemorrhage (HP:0005261) | 4.79798109 |
| 13 | Increased IgM level (HP:0003496) | 4.21626205 |
| 14 | Gingival bleeding (HP:0000225) | 4.12835591 |
| 15 | Recurrent skin infections (HP:0001581) | 3.97715290 |
| 16 | Interstitial pulmonary disease (HP:0006530) | 3.84086864 |
| 17 | Abnormality of macrophages (HP:0004311) | 3.75057204 |
| 18 | Chronic obstructive pulmonary disease (HP:0006510) | 3.71605668 |
| 19 | Obstructive lung disease (HP:0006536) | 3.71605668 |
| 20 | Myocardial infarction (HP:0001658) | 3.66737979 |
| 21 | Recurrent fungal infections (HP:0002841) | 3.59688618 |
| 22 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.57547273 |
| 23 | Recurrent cutaneous fungal infections (HP:0011370) | 3.57547273 |
| 24 | Stomatitis (HP:0010280) | 3.49130705 |
| 25 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.45541983 |
| 26 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.45541983 |
| 27 | Abnormality of glycolipid metabolism (HP:0010969) | 3.45541983 |
| 28 | Menorrhagia (HP:0000132) | 3.41039052 |
| 29 | Prolonged neonatal jaundice (HP:0006579) | 3.32015528 |
| 30 | Abnormality of the common coagulation pathway (HP:0010990) | 3.31994373 |
| 31 | Disinhibition (HP:0000734) | 3.30749002 |
| 32 | Hyperphosphatemia (HP:0002905) | 3.27166912 |
| 33 | IgA deficiency (HP:0002720) | 3.27071155 |
| 34 | Mediastinal lymphadenopathy (HP:0100721) | 3.21646648 |
| 35 | Gingivitis (HP:0000230) | 3.16667107 |
| 36 | Hemorrhage of the eye (HP:0011885) | 3.09559292 |
| 37 | Agnosia (HP:0010524) | 3.04750307 |
| 38 | Vascular calcification (HP:0004934) | 3.04395529 |
| 39 | Osteomalacia (HP:0002749) | 3.00899122 |
| 40 | Cheilitis (HP:0100825) | 2.98115466 |
| 41 | Porencephaly (HP:0002132) | 2.91929564 |
| 42 | Reduced antithrombin III activity (HP:0001976) | 2.90654151 |
| 43 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.89947821 |
| 44 | Fatigue (HP:0012378) | 2.88420034 |
| 45 | Increased cerebral lipofuscin (HP:0011813) | 2.88020586 |
| 46 | 3-Methylglutaconic aciduria (HP:0003535) | 2.85966726 |
| 47 | Recurrent pneumonia (HP:0006532) | 2.80696982 |
| 48 | Cardiovascular calcification (HP:0011915) | 2.77268637 |
| 49 | Petechiae (HP:0000967) | 2.73137481 |
| 50 | Cellulitis (HP:0100658) | 2.71424551 |
| 51 | Periodontitis (HP:0000704) | 2.71423312 |
| 52 | IgM deficiency (HP:0002850) | 2.67545673 |
| 53 | Wide intermamillary distance (HP:0006610) | 2.67334518 |
| 54 | Abnormality of the intrinsic pathway (HP:0010989) | 2.62384655 |
| 55 | Vasculitis (HP:0002633) | 2.56347736 |
| 56 | Bone pain (HP:0002653) | 2.50356675 |
| 57 | Hepatosplenomegaly (HP:0001433) | 2.42227706 |
| 58 | Micronodular cirrhosis (HP:0001413) | 2.38787403 |
| 59 | Fused cervical vertebrae (HP:0002949) | 2.37287253 |
| 60 | Urticaria (HP:0001025) | 2.35972097 |
| 61 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.31236538 |
| 62 | Apathy (HP:0000741) | 2.27630253 |
| 63 | Lower limb hyperreflexia (HP:0002395) | 2.27189835 |
| 64 | Nausea (HP:0002018) | 2.25358156 |
| 65 | Thyroiditis (HP:0100646) | 2.21152256 |
| 66 | Diminished motivation (HP:0000745) | 2.20494715 |
| 67 | Right ventricular cardiomyopathy (HP:0011663) | 2.17433994 |
| 68 | Recurrent lower respiratory tract infections (HP:0002783) | 2.13793803 |
| 69 | Epistaxis (HP:0000421) | 2.12397036 |
| 70 | Pigmentary retinal degeneration (HP:0001146) | 2.08165416 |
| 71 | Abnormality of proline metabolism (HP:0010907) | 2.07902366 |
| 72 | Hydroxyprolinuria (HP:0003080) | 2.07902366 |
| 73 | Abnormality of the basal ganglia (HP:0002134) | 2.07760730 |
| 74 | Hypergammaglobulinemia (HP:0010702) | 2.07471874 |
| 75 | Purpura (HP:0000979) | 2.04878365 |
| 76 | Nephritis (HP:0000123) | 2.04839335 |
| 77 | Neurofibrillary tangles (HP:0002185) | 2.04489467 |
| 78 | Progressive visual loss (HP:0000529) | 2.02217475 |
| 79 | Myopathic facies (HP:0002058) | 2.01528471 |
| 80 | Severe muscular hypotonia (HP:0006829) | 2.00867907 |
| 81 | Upper motor neuron abnormality (HP:0002127) | 2.00241003 |
| 82 | Recurrent bronchitis (HP:0002837) | 1.99844832 |
| 83 | Gastrointestinal stroma tumor (HP:0100723) | 1.93890332 |
| 84 | Bone cyst (HP:0012062) | 1.91638578 |
| 85 | Hematuria (HP:0000790) | 1.87549744 |
| 86 | Esophageal varix (HP:0002040) | 1.87543984 |
| 87 | Osteomyelitis (HP:0002754) | 1.86866674 |
| 88 | Skin ulcer (HP:0200042) | 1.86864486 |
| 89 | T lymphocytopenia (HP:0005403) | 1.85895646 |
| 90 | Sepsis (HP:0100806) | 1.85870183 |
| 91 | Conjunctival telangiectasia (HP:0000524) | 1.85687509 |
| 92 | Autoimmune thrombocytopenia (HP:0001973) | 1.84095174 |
| 93 | Tetraparesis (HP:0002273) | 1.81274415 |
| 94 | Cortical dysplasia (HP:0002539) | 1.80106874 |
| 95 | Cleft eyelid (HP:0000625) | 1.79659326 |
| 96 | Arthralgia (HP:0002829) | 1.79301676 |
| 97 | Abnormality of T cell number (HP:0011839) | 1.78939530 |
| 98 | Cerebral hemorrhage (HP:0001342) | 1.77778992 |
| 99 | Cutaneous photosensitivity (HP:0000992) | 1.75938306 |
| 100 | IgG deficiency (HP:0004315) | 1.74093625 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PBK | 9.52015718 |
| 2 | ERBB3 | 5.59928206 |
| 3 | TRPM7 | 3.94639046 |
| 4 | MAP3K14 | 3.40219222 |
| 5 | RIPK4 | 3.16203716 |
| 6 | TBK1 | 2.96573806 |
| 7 | MST4 | 2.90967314 |
| 8 | BMPR2 | 2.75440782 |
| 9 | ABL2 | 2.36214059 |
| 10 | NEK9 | 1.98583324 |
| 11 | IKBKB | 1.96329026 |
| 12 | TAOK3 | 1.67168743 |
| 13 | EPHA2 | 1.56839088 |
| 14 | LIMK1 | 1.54712855 |
| 15 | TESK1 | 1.54404393 |
| 16 | BLK | 1.50660585 |
| 17 | IRAK4 | 1.46204847 |
| 18 | STK4 | 1.41913708 |
| 19 | TXK | 1.39942728 |
| 20 | MST1R | 1.17238364 |
| 21 | IKBKE | 1.16198193 |
| 22 | CHUK | 1.14476414 |
| 23 | MAP4K1 | 1.11242435 |
| 24 | MAP3K13 | 1.09406557 |
| 25 | SYK | 1.05814489 |
| 26 | HCK | 1.03297537 |
| 27 | EIF2AK1 | 1.01525411 |
| 28 | LATS1 | 1.01506904 |
| 29 | JAK3 | 0.94264691 |
| 30 | BMX | 0.92825967 |
| 31 | PIM2 | 0.91873043 |
| 32 | KSR2 | 0.88735750 |
| 33 | TYK2 | 0.88527645 |
| 34 | LCK | 0.84400867 |
| 35 | MAP3K2 | 0.81613900 |
| 36 | EPHB1 | 0.80071447 |
| 37 | MET | 0.78081000 |
| 38 | ABL1 | 0.76543132 |
| 39 | MOS | 0.74237587 |
| 40 | CSK | 0.73373939 |
| 41 | JAK1 | 0.72955480 |
| 42 | MATK | 0.72457146 |
| 43 | ERBB4 | 0.71789647 |
| 44 | ACVR1B | 0.70071911 |
| 45 | TAOK1 | 0.69505067 |
| 46 | ZAK | 0.68007589 |
| 47 | RPS6KA4 | 0.64655253 |
| 48 | JAK2 | 0.64538741 |
| 49 | STK10 | 0.64141514 |
| 50 | EGFR | 0.59682173 |
| 51 | LYN | 0.57734425 |
| 52 | FGR | 0.57588880 |
| 53 | MAP3K1 | 0.56896760 |
| 54 | TTN | 0.54460054 |
| 55 | NEK6 | 0.54284907 |
| 56 | PIK3CA | 0.52789741 |
| 57 | ICK | 0.50601470 |
| 58 | MAPK12 | 0.50356898 |
| 59 | FES | 0.48462711 |
| 60 | TNIK | 0.47954574 |
| 61 | PRKCD | 0.47716185 |
| 62 | DDR2 | 0.43112596 |
| 63 | PRKCQ | 0.41060734 |
| 64 | PIM1 | 0.38899739 |
| 65 | NUAK1 | 0.37873130 |
| 66 | IRAK3 | 0.35828865 |
| 67 | SRC | 0.34828782 |
| 68 | CDC42BPA | 0.34307938 |
| 69 | MAP2K1 | 0.30815462 |
| 70 | CSF1R | 0.30667115 |
| 71 | BMPR1B | 0.29411565 |
| 72 | DAPK2 | 0.29349723 |
| 73 | RET | 0.29027277 |
| 74 | KIT | 0.28145035 |
| 75 | DAPK3 | 0.27809890 |
| 76 | PTK6 | 0.27627450 |
| 77 | PRKCH | 0.25546037 |
| 78 | BTK | 0.24664156 |
| 79 | YES1 | 0.22381591 |
| 80 | PTK2 | 0.21938381 |
| 81 | FYN | 0.21714954 |
| 82 | STK3 | 0.21367452 |
| 83 | PAK4 | 0.20607611 |
| 84 | FRK | 0.20451708 |
| 85 | DMPK | 0.19237238 |
| 86 | ROCK2 | 0.19229081 |
| 87 | IGF1R | 0.17748706 |
| 88 | NTRK3 | 0.17133633 |
| 89 | NME1 | 0.16412523 |
| 90 | GRK7 | 0.15583250 |
| 91 | LATS2 | 0.14906360 |
| 92 | PRKACG | 0.14159319 |
| 93 | LRRK2 | 0.13702103 |
| 94 | ERN1 | 0.13551237 |
| 95 | PRKG1 | 0.13513869 |
| 96 | PKN1 | 0.13252892 |
| 97 | MAP2K2 | 0.13214259 |
| 98 | SGK1 | 0.12927725 |
| 99 | PDK2 | 0.11887813 |
| 100 | TGFBR1 | 0.11564881 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Allograft rejection_Homo sapiens_hsa05330 | 3.46619271 |
| 2 | Sulfur metabolism_Homo sapiens_hsa00920 | 3.18272206 |
| 3 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 3.08120114 |
| 4 | Leishmaniasis_Homo sapiens_hsa05140 | 3.04229491 |
| 5 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.79841859 |
| 6 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 2.65143666 |
| 7 | Viral myocarditis_Homo sapiens_hsa05416 | 2.59597102 |
| 8 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.46113038 |
| 9 | Asthma_Homo sapiens_hsa05310 | 2.42165550 |
| 10 | Phagosome_Homo sapiens_hsa04145 | 2.37083773 |
| 11 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.36074484 |
| 12 | Malaria_Homo sapiens_hsa05144 | 2.19963608 |
| 13 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.05243707 |
| 14 | Tuberculosis_Homo sapiens_hsa05152 | 1.97706178 |
| 15 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.95907079 |
| 16 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.94729834 |
| 17 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.93022216 |
| 18 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.90706022 |
| 19 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.89649176 |
| 20 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.88075633 |
| 21 | Lysosome_Homo sapiens_hsa04142 | 1.87048062 |
| 22 | Pertussis_Homo sapiens_hsa05133 | 1.83092329 |
| 23 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.53080546 |
| 24 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.52626072 |
| 25 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.51535075 |
| 26 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.37461630 |
| 27 | Legionellosis_Homo sapiens_hsa05134 | 1.36179119 |
| 28 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.32400150 |
| 29 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.31920275 |
| 30 | Salmonella infection_Homo sapiens_hsa05132 | 1.30237846 |
| 31 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.29263433 |
| 32 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.27003190 |
| 33 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.16825785 |
| 34 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.14788543 |
| 35 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.11437659 |
| 36 | Influenza A_Homo sapiens_hsa05164 | 1.07102505 |
| 37 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.03991681 |
| 38 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.02239249 |
| 39 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.01584500 |
| 40 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.01196816 |
| 41 | Apoptosis_Homo sapiens_hsa04210 | 0.97664602 |
| 42 | Amoebiasis_Homo sapiens_hsa05146 | 0.96658649 |
| 43 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.94590647 |
| 44 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.94519447 |
| 45 | Measles_Homo sapiens_hsa05162 | 0.93320039 |
| 46 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.90809914 |
| 47 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.88939228 |
| 48 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.84104892 |
| 49 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.82418026 |
| 50 | Shigellosis_Homo sapiens_hsa05131 | 0.81314234 |
| 51 | Mineral absorption_Homo sapiens_hsa04978 | 0.80124720 |
| 52 | Proteasome_Homo sapiens_hsa03050 | 0.76575604 |
| 53 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.76418792 |
| 54 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.72588566 |
| 55 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.72486081 |
| 56 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.70949889 |
| 57 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.70195975 |
| 58 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.69774562 |
| 59 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.68129723 |
| 60 | Platelet activation_Homo sapiens_hsa04611 | 0.64936330 |
| 61 | Adherens junction_Homo sapiens_hsa04520 | 0.64029915 |
| 62 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.63519149 |
| 63 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.63206859 |
| 64 | Hepatitis C_Homo sapiens_hsa05160 | 0.62712088 |
| 65 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.61768438 |
| 66 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.61270756 |
| 67 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.54915002 |
| 68 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.53200927 |
| 69 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.53071085 |
| 70 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.52205355 |
| 71 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.51675997 |
| 72 | Parkinsons disease_Homo sapiens_hsa05012 | 0.47424738 |
| 73 | Histidine metabolism_Homo sapiens_hsa00340 | 0.46326984 |
| 74 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.45463450 |
| 75 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.39429256 |
| 76 | Peroxisome_Homo sapiens_hsa04146 | 0.35294773 |
| 77 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.34148238 |
| 78 | Thyroid cancer_Homo sapiens_hsa05216 | 0.34078946 |
| 79 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.33917215 |
| 80 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.31520951 |
| 81 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.31222773 |
| 82 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.30682635 |
| 83 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.30098093 |
| 84 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.27049566 |
| 85 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.25721653 |
| 86 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.24800474 |
| 87 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.24729456 |
| 88 | Hepatitis B_Homo sapiens_hsa05161 | 0.23620638 |
| 89 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.23620420 |
| 90 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.23550732 |
| 91 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.23454880 |
| 92 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.22251297 |
| 93 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.21056096 |
| 94 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.19243420 |
| 95 | Endocytosis_Homo sapiens_hsa04144 | 0.19177452 |
| 96 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.18439821 |
| 97 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.17099428 |
| 98 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.16419128 |
| 99 | GABAergic synapse_Homo sapiens_hsa04727 | 0.16326221 |
| 100 | Long-term potentiation_Homo sapiens_hsa04720 | 0.15781834 |

